Last update 11 Jul 2024
Bausch Health Cos., Inc.

Bausch Health Cos., Inc.

Public Company|
1959|
Canada
|
10,000-50,000
| TSX: BHC|

Overview

Basic Info

Introduction
Bausch Health Cos., Inc. is a multinational corporation that specializes in the research, production, and distribution of a diverse range of pharmaceuticals, medical devices, and over-the-counter items. The company operates through five primary business segments, including Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. Bausch Health's Salix division focuses on sales of gastrointestinal (GI) products in the United States, particularly the Xifaxan product line. The International segment encompasses sales of branded pharmaceuticals, branded generics, and OTC products outside the US and Puerto Rico, excluding Bausch + Lomb products and Solta aesthetic medical devices. Solta Medical segment deals with global sales of Solta Medical aesthetic medical devices. Diversified Products segment includes sales in the US of pharmaceutical products in neurology and other therapeutic areas, generics, ortho dermatologics, and dentistry products. Finally, the Bausch + Lomb segment covers global sales of Bausch + Lomb vision care, surgical, and ophthalmic pharmaceuticals products. Bausch Health Cos., Inc. was established on March 29, 1994 and is headquartered in Laval, Canada.

Tags

Other Diseases
Skin and Musculoskeletal Diseases
Nervous System Diseases
Small molecule drug
Monoclonal antibody
Shared antigen vaccine

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Small molecule drug86
Monoclonal antibody2
Enzyme1
Shared antigen vaccine1
Chemical drugs1

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 14 Jul 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
1
1
Phase 1 Clinical
Phase 2 Clinical
3
2
Phase 3 Clinical
NDA/BLA
1
85
Approved
Other
138
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free